BiomarkersHuman trial3 yearsRandomised trialPlacebo-controlled

Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysis

Journal of the Endocrine Society

The paper

Rodolfo Javier Galindo, Georgios K. Dimitriadis, Adam Stefański,

Kieren J. Mather, Dachuang Cao, Rhea Lewis,

University of Miami · Eli Lilly (United States)

Journal of the Endocrine Society · 19 Aug 2026

doi.org/10.1210/jendso/bvag190 PubMed 42656588

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Type 2 diabetes prevalence fell in Mauritius after 2009
The Lancet Diabetes & Endocrinology · 4 Oct 2026
Nutrient deficits linked to higher metabolic risks in obesity
Nutrients · 4 Oct 2026